Feprazone in osteoarthritis: comparison of twice and 3-times daily dosage regimens
Laurent, M.R.; Berry, D.; Grahame, R.
Pharmatherapeutica 3(6): 393-397
1983
ISSN/ISBN: 0308-051X PMID: 6353430 Document Number: 197447
In a double-blind crossover trial, 200 mg feprazone 3-times a day was compared with 200 mg twice a day in the treatment of osteoarthritis. There was no difference in clinical efficacy or in adverse effects between the two dosage schedules. Because of its long elimination half-life (approximately 24 hours) it is suggested that feprazone should be given in twice daily dosage and is a simple and effective treatment for osteoarthritis.
Document emailed within 1 workday
Related Documents
Wasmuth, J.-C.; la Porte, C.J.L.; Schneider, K.; Burger, D.M.; Rockstroh, J.K. 2004: Comparison of two reduced-dose regimens of indinavir (600 mg vs 400 mg twice daily) and ritonavir (100 mg twice daily) in healthy volunteers (COREDIR) Antiviral Therapy 9(2): 213-220Mauracher, E.H.; Lau, W.Y.; Kartowisastro, H.; Ong, K.H.; Genato, V.X.; Limson, B.; Yusi, G.M.; Liu, C.Y.; Suwangool, P. 1989: Comparison of once-daily and thrice-daily netilmicin regimens in serious systemic infections: a multicenter study in six Asian countries Clinical Therapeutics 11(5): 604-613
Boldt, J.; Knothe, C.; Zickmann, B.; Wege, N.; Dapper, F.; Hempelmann, G. 1993: Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss Journal of Thoracic and Cardiovascular Surgery 105(4): 705-711
Sehgal, N.V.; Parikh, S. 1981: Treatment of Psoriasis: Comparison of 8-methoxysoralen and 4,5,8- Trimethylpsoralen Using Sunlight (low Dosage Daily Regime) Indian Journal of Dermatology Venereology and Leprology 47(1): 6-8
Karachalios, G.N.; Houpas, P.; Tziviskou, E.; Papalimneou, V.; Georgiou, A.; Karachaliou, I.; Halkiadaki, D. 1998: Prospective randomized study of once-daily versus twice-daily amikacin regimens in patients with systemic infections International Journal of Clinical Pharmacology and Therapeutics 36(10): 561-564
Kropp, R.; Goebel, D.; Matthiessen, W.; Goetzke, A.; Forschbach, G.; Radenbach, K.L.; Wentz, D. 1986: Comparison of 3 times weekly versus daily corticosteroid administration in sarcoidosis. A prospective, randomized multicenter study of the Scientific Society for the Therapy of Lung Diseases Praxis und Klinik der Pneumologie 40(4): 123-128
Ahtoy, P.; Chrétien, P.; Dupain, T.; Rauch, C.; Rouchouse, A.; Delfolie, A. 2002: Alfuzosin, an alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia: once daily versus 3 times daily dosing in healthy subjects International Journal of Clinical Pharmacology and Therapeutics 40(7): 289-294
Wheat, L.J.; Farthing, C.; Cohen, C.; Pierone, G.; Lalezari, J.; Pilson, R.S.; Siemon-Hryczyk, P. 2002: Efficacy and safety of twice-daily versus three-times daily saquinavir soft gelatin capsules as part of triple combination therapy for HIV-1 infection Antiviral Therapy 7(3): 199-209
Jehl, F.; Klossek, J.M.; Peynegre, R.; Serrano, E.; Castillo, L.; Bobin, S.; Desprez, D.; Renault, C.; Neel, V.; Rouffiac, E.; Borie, C. 2002: Sinusal penetration of amoxicillin-clavulanic acid. Formulation 1 g./125 mg., twice daily versus formulation 500 mg./125 mg., three times daily Presse Medicale 31(34): 1596-1603
Levy, R.H.; Smith, G.H. 1973: Dosage regimens of antiarrhythmics. II. Applications American Journal of Hospital Pharmacy 30(6): 494-498
Levy, R.H.; Smith, G.H. 1973: Dosage regimens of antiarrhythmics. 1. Pharmacokinetic properties American Journal of Hospital Pharmacy 30(5): 398-404
Crevasse, L.; Robinson, J.D.; Ariet, M.; Sung, J. 1988: A program for optimizing drug dosage regimens: digoxin M.D. Computing: Computers in Medical Practice 5(2): 27-35
Goicoechea, F.J.; Jelliffe, R.W. 1974: Computerized dosage regimens for highly toxic drugs American Journal of Hospital Pharmacy 31(1): 67-71
Mah, J.T.; Wong, J.Y.; Lee, E.J. 2000: Pharmacogenetics: role in modifying drug dosage regimens Annals of the Academy of Medicine Singapore 29(5): 628-632
Strachunskiĭ, A.S.; Mukonin, A.A. 2000: The effect of the pharmacodynamics of different classes of antibacterial preparations on their dosage regimens Antibiotiki i Khimioterapiia 45(4): 40-44
Richter, O.; Reinhardt, D. 1982: Methods for evaluating optimal dosage regimens and their application to theophylline International Journal of Clinical Pharmacology Therapy and Toxicology 20(12): 564-575
Corren, J.; Berkowitz, R.; Murray, J.J.; Prenner, B. 2003: Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma International Journal of Clinical Practice 57(7): 567-572
Castañeda-Hernández, G.; Hoyo-Vadillo, C.; Herrera, J.E.; Salazar, L.A.; Ortiz, C.; Hong, E. 1991: Accumulation of cinnarizine, a calcium entry blocker, following usual dosage regimens Proceedings of the Western Pharmacology Society 34: 421-424
Jelliffe, R.W.; Buell, J.; Kalaba, R. 1972: Reducation of digitalis toxicity by computer-assisted glycoside dosage regimens Annals of Internal Medicine 77(6): 891-906
Quintaliani, G.; Buoncristiani, U.; Fagugli, R.; Kuluiranu, H.; Ciao, G.; Rondini, L.; Lowenthal, D.T.; Reboldi, G. 2000: Survival of vascular access during daily and three times a week hemodialysis Clinical Nephrology 53(5): 372-377